{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:03:55Z","timestamp":1787061835632,"version":"build-2736575974"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2016,3,7]],"date-time":"2016-03-07T00:00:00Z","timestamp":1457308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0149615","type":"journal-article","created":{"date-parts":[[2016,3,7]],"date-time":"2016-03-07T13:33:38Z","timestamp":1457357618000},"page":"e0149615","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":86,"title":["Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist Protocol"],"prefix":"10.1371","volume":"11","clinical-trial-number":[{"clinical-trial-number":"nct00696800","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00702845","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00696878","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Georg","family":"Griesinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre J. M.","family":"Verweij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davis","family":"Gates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Devroey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara J.","family":"Stegmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basil C.","family":"Tarlatzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,3,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1093\/humrep\/dei253","article-title":"Complications of IVF and ovulation induction","volume":"20","author":"R Klemetti","year":"2005","journal-title":"Hum Reprod"},{"key":"ref2","first-page":"3","article-title":"Ovarian hyperstimulation syndrome: current views on pathophysiology, risk factors, prevention, and management","volume":"6","author":"MM Alper","year":"2009","journal-title":"J Exp Clin Assist Reprod"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.rbmo.2012.01.005","article-title":"Comparative incidence of ovarian hyperstimulation syndrome following ovarian stimulation with corifollitropin alfa or recombinant FSH","volume":"24","author":"BC Tarlatzis","year":"2012","journal-title":"Reprod Biomed Online"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1385\/ENDO:26:3:285","article-title":"Understanding ovarian hyperstimulation syndrome","volume":"26","author":"A Delbaere","year":"2005","journal-title":"Endocrine"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0015-0282(00)00492-1","article-title":"Distinction between early and late ovarian hyperstimulation syndrome","volume":"73","author":"RS Mathur","year":"2000","journal-title":"Fertil Steril"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/humupd\/dml038","article-title":"Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis","volume":"12","author":"EM Kolibianakis","year":"2006","journal-title":"Hum Reprod Update"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.rbmo.2010.03.019","article-title":"Corifollitropin alfa for ovarian stimulation in IVF: a randomized trial in lower-body-weight women","volume":"21","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1093\/humrep\/dep291","article-title":"A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol","volume":"24","author":"P Devroey","year":"2009","journal-title":"Hum Reprod"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1093\/humrep\/der163","article-title":"Repeated ovarian stimulation with corifollitropin alfa in patients in a GnRH antagonist protocol: no concern for immunogenicity","volume":"26","author":"RJ Norman","year":"2011","journal-title":"Hum Reprod"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.fertnstert.2005.07.1292","article-title":"Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles","volume":"85","author":"EG Papanikolaou","year":"2006","journal-title":"Fertil Steril"},{"key":"ref11","first-page":"1","article-title":"Agents stimulating gonadal function in the human. Report of a WHO scientific group","volume":"514","journal-title":"World Health Organ Tech Rep Ser"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1477-7827-5-9","article-title":"Ovarian volume and antral follicle count for the prediction of low and hyper responders with in vitro fertilization","volume":"5","author":"J Kwee","year":"2007","journal-title":"Reprod Biol Endocrinol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.3109\/00016340903287482","article-title":"Prediction of ovarian hyperstimulation syndrome in women undergoing in vitro fertilization","volume":"88","author":"A Kahnberg","year":"2009","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/humupd\/8.6.559","article-title":"Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review","volume":"8","author":"A Delvigne","year":"2002","journal-title":"Hum Reprod Update"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S1472-6483(10)60652-9","article-title":"GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis","volume":"13","author":"G Griesinger","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fertnstert.2003.05.032","article-title":"Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome","volume":"81","author":"S Kol","year":"2004","journal-title":"Fertil Steril"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/humrep\/dem006","article-title":"Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study","volume":"22","author":"G Griesinger","year":"2007","journal-title":"Hum Reprod"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.fertnstert.2011.01.163","article-title":"Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a "freeze-all" strategy: a prospective multicentric study","volume":"95","author":"G Griesinger","year":"2011","journal-title":"Fertil Steril"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.fertnstert.2008.12.019","article-title":"Triggering ovulation with gonadotropin-releasing hormone agonist in in vitro fertilization patients with polycystic ovaries does not cause ovarian hyperstimulation syndrome despite very high estradiol levels","volume":"93","author":"MA Manzanares","year":"2010","journal-title":"Fertil Steril"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.fertnstert.2013.11.005","article-title":"Cabergoline for the prevention of ovarian hyperstimulation syndrome: systematic review and meta-analysis of randomized controlled trials","volume":"101","author":"VM Leitao","year":"2014","journal-title":"Fertil Steril"},{"key":"ref21","first-page":"CD008605","article-title":"Cabergoline for preventing ovarian hyperstimulation syndrome","volume":"2","author":"H Tang","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"ref22","first-page":"CD006105","article-title":"Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome","volume":"11","author":"LO Tso","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1472-6483(10)60168-X","article-title":"Effect of different gonadotrophin priming on IVM of oocytes from women with normal ovaries: a prospective randomized study","volume":"19","author":"R Fadini","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.fertnstert.2012.04.046","article-title":"In vitro maturation or in vitro fertilization for women with polycystic ovaries? A case-control study of 194 treatment cycles","volume":"98","author":"AS Gremeau","year":"2012","journal-title":"Fertil Steril"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.fertnstert.2012.06.055","article-title":"Improved implantation and ongoing pregnancy rates after single-embryo transfer with an optimized protocol for in vitro oocyte maturation in women with polycystic ovaries and polycystic ovary syndrome","volume":"98","author":"SM Junk","year":"2012","journal-title":"Fertil Steril"},{"key":"ref26","first-page":"665","article-title":"A comparison of in vitro maturation and in vitro fertilization for women with polycystic ovaries","volume":"100","author":"TJ Child","year":"2002","journal-title":"Obstet Gynecol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/humrep\/deu248","article-title":"In vitro maturation as an alternative to standard in vitro fertilization for patients diagnosed with polycystic ovaries: a comparative analysis of fresh, frozen and cumulative cycle outcomes","volume":"30","author":"ML Walls","year":"2015","journal-title":"Hum Reprod"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1093\/humrep\/der251","article-title":"An OHSS-Free Clinic by segmentation of IVF treatment","volume":"26","author":"P Devroey","year":"2011","journal-title":"Hum Reprod"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0149615","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T22:01:17Z","timestamp":1540332077000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0149615"}},"subtitle":[],"editor":[{"given":"Cheng-Guang","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,3,7]]},"references-count":28,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0149615","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,7]]}}}